SCHEMBL10378571

SCHEMBL10378571

Cc1[nH]c(=O)ccc1C(=O)c1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NR4A1 P22736 1/20 0.45
▸ KMT2A Q03164 3/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.43
▸ MAPT P10636 3/20 0.43
▸ SRD5A2 P31213 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HPGD P15428 1/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ CES2 O00748 1/20 0.42
▸ CES1 P23141 1/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ SIRT1 Q96EB6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10377556 0.86 ALDH1A1 (0.52) NR4A1MAPTSRD5A2HPGDRAB9A
SCHEMBL10378565 0.85 MAPT (0.47) KMT2AMAPTSRD5A2MAPK1HPGD
SCHEMBL10378678 0.83 GRM5 (0.43) KMT2AMAPTRAB9ACES2CES1
SCHEMBL10377589 0.83 MAPT (0.46) KMT2ANPSR1MAPTMAPK1HPGD
SCHEMBL10378560 0.83 MAPT (0.47) KMT2ANPSR1MAPTMAPK1HPGD
SCHEMBL10377417 0.81 NPC1 (0.54) KMT2ANPSR1MAPTMAPK1HPGD
SCHEMBL10377414 0.81 PLK1 (0.45) KMT2AMAPTSRD5A2HPGDRAB9A
SCHEMBL10377855 0.80 CA1 (0.42) MAPTPKM
SCHEMBL10378895 0.78 MAPT (0.50) KMT2ANPSR1MAPTSRD5A2MAPK1
SCHEMBL10377444 0.77 KDM4E (0.56) KMT2ANPSR1MAPTMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4560691-A 5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation STERLING DRUG INC. (US) 1985-12-24 — — US claimed
EP-0168037-B1 1-6-NAPHTHYRIDIN-2(1H)-ONES USEFUL AS CARDIOTONICS STERLING DRUG INC. (US) 1990-02-07 — — EP disclosed
EP-0168037-A2 1-6-Naphthyridin-2(1H)-ones useful as cardiotonics STERLING DRUG INC. (US) 1986-01-15 — — EP disclosed
US-4560691-A 5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation STERLING DRUG INC. (US) 1985-12-24 — — US disclosed
Send feedback